The new organization acquires Savioke R&D and the Relay product line. It will continue to focus primarily on hospitality and healthcare.
At the Healthcare Robotics Engineering Forum, the Festo-MassRobotics Healthcare Robotics Startup Catalyst will celebrate the milestones achieved four startups.
Rich Mahoney, Vice President of Research at Intuitive, will discuss the opportunity for healthcare robotics solutions to expand access to quality healthcare at the event.
Compared with Q1 2021, sales were down 14% in the bottom line and 15% growth in sales.
RobotCT’s UGO exoskeleton robot helps patients who experience motor dysfunction in the lower body learn how to walk.
Diligent plans to use the round of funding to optimize supply chain and design teams for faster deployments of Moxi.
Phil Duffy, chief product officer at Embodied, will discuss the development of the Moxie companion robot.
A laser mounted to a robotic arm cuts the bone, automatically guided along the cuts based on pre-operation navigation planning and simulations.
The combined company will offer an extended product portfolio to target a much broader spectrum of customers across the commercial and defense sectors.
Zeta Surgical plans to use the seed funding to finish developing Zeta, its neurosurgical navigation platform.
Researchers aim to improve the lives of people with neuro-motor impairments and to help individuals achieve ambitious fitness goals.
The company plans to use the financing to further develop its lab automation platform Automata Labs for use in and outside of the UK.
Kinova has been working with Auris Health to develop a purpose-built robotic arm to help enable meaningful progress in surgery.
The goal is standardized, quantifiable training on the Hominis surgical system.
For the last decade, scientists have been trying to figure out how to use surface electromyography (EMG) signals to control prosthetic limbs.
Kinova makes a variety of robotic arms. Kinova said new products for industrial markets will be announced later in 2022.
The round was led by SoftBank Vision Fund 2, and included support from Saudi Aramco P7 Venture Fund and the Yuanjing Vision Plus Capital.
Cornerstone Capital, a Chinese private equity investment institution, led the funding round for Yuanhua Intelligent Technologies.
Distalmotion plans to use the funding to commercialize Dexter globally, and pursue FDA approval for the system.
Worldwide procedures performed with the da Vinci surgical robot increased 19% compared to the fourth quarter of 2020.
Atalante is a self-balanced, lower-body exoskeleton that emulates the way humans walk. The company began clinical trials for the exoskeleton in 2017. It was CE marked in 2019.
Memic’s Hominis system will be used in single-site, natural orifice laparoscopic-assisted transvaginal benign gynecological procedures.